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ttp://dx.doi.org/10.1016/j.ajpath.2014.07.013WFDC1/ps20 is a whey acidic protein four-disulﬁde core member that exhibits diverse growth and
immune-associated functions in vitro. In vivo functions are unknown, although WFDC1 is lower in reactive
stroma. A Wfdc1-null mouse was generated to assess core functions. Wfdc1-null mice exhibited normal
developmental and adult phenotypes. However, homeostasis challenges affected inﬂammatory and repair
processes. Wfdc1-null mice infected with inﬂuenza A exhibited 2.75elog-fold lower viral titer relative to
control mice.Wfdc1-null infected lungs exhibited elevated macrophages and deposition of osteopontin, a
potent macrophage chemokine. In wounding studies, Wfdc1-null mice exhibited an elevated rate of skin
closure, and this too was associated with elevated deposition of osteopontin and macrophage recruit-
ment. Wfdc1-null ﬁbroblasts exhibited impaired spheroid formation, elevated adhesion to ﬁbronectin,
and an increased rate of wound closure in vitro. This was reversed by neutralizing antibody to osteopontin.
Osteopontin mRNA and cleaved protein was up-regulated in Wfdc1-null cells treated with lipopolysac-
charide or polyinosinic-polycytidylic acid coordinate with constitutively active matrix metallopeptidase-9
(MMP-9), a protease that cleaves osteopontin. These data suggest that WFDC1/ps20 modulates core host
response mechanisms, in part, via regulation of osteopontin and MMP-9 activity. Release from WFDC1
regulation is likely a key component of inﬂammatory and repair response mechanisms, and involves the
processing of elevated osteopontin by activated MMP-9, and subsequent macrophage recruitment.
(Am J Pathol 2014, 184: 2951e2964; http://dx.doi.org/10.1016/j.ajpath.2014.07.013)Supported by NIH grants R01 CA58093 and R01 DK083293 (D.R.R.);
NCI Cancer Center Support grant P30 CA125123 (the Dan L. Duncan
Cancer Center at Baylor College of Medicine); and the Genetically Engi-
neered Mouse (GEM) Shared Resource (Baylor College of Medicine).
The funders had no role in the study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Disclosures: None declared.
Current address of S.J.R., Aptalis Pharmaceuticals, Bridgewater, NJ; of
I.G.S., Department of Mathematics and Life Sciences, Brazosport College,
Lake Jackson, TX; and of D.A.B., Department of Radiation Oncology,
Memorial Sloan-Kettering Cancer Center, New York, NY.Wehave previously reported the growth inhibitory functions
of ps20 in vitro,1,2 puriﬁed the secreted ps20 protein,3 and
cloned the rodent and human WFDC1 genes encoding
ps20.4,5 Rodent and humanmRNAencoding ps20 are highly
conserved, exhibit a canonical four-disulﬁde core domain
typical of the whey acidic protein (WAP) family, and
localize to human chromosome 16q24.4,5 By contrast, many
of the other WAP family members are clustered on chro-
mosome 20q13, suggesting WFDC1 had a divergent
evolutionary origin.4,6 Eighteen human WAP proteins have
been identiﬁed; most are secreted factors that exhibit pro-
tease inhibitory activity and contain at least one canonical
four-disulﬁde core domain.7 The WAP family members
exhibit several diverse biological functions associated with
immune responses and antimicrobial activity.6 However, the
biology and function of WFDC1/ps20 in vivo is poorly
understood.stigative Pathology.
.Several in vitro studies suggestedWFDC1/ps20 functions in
stromaleepithelial interactions and tissue homeostasis.1e3
Further study showed that WFDC1/ps20 expression was
reduced in reactive stroma in human prostate cancer, and this
was predictive of prostate cancer progression.8 Reactive stroma
in cancer is very similar to wound repair reactive stroma
generally observed at sites of altered tissue homeostasis,
Ressler et alincluding wound repair, ﬁbrosis, cancer, and cardiovascular
disease.9e11 Conversely, in vivo studies showed that over-
expression of WFDC1/ps20 in a recombined cancer/stromal
cell mixed xenograft model resulted in elevated tumorigenesis
attributable to elevated angiogenesis.12 Together, these studies
suggest that WFDC1/ps20 functions in adult tissue homeo-
stasis by modulating cell proliferation, adhesion, and
migration.
Additional studies support the notion that WFDC1/ps20
functions during infection processes and immune re-
sponses. Human WFDC1/ps20 promoted HIV infection in
CD4 T cells by up-regulating intercellular adhesion mole-
cule 1,13 whereas murine Wfdc1 limited murine hepatitis
virus infectivity and neutrophil recruitment14 in our mouse
model, suggesting differential innate immune functions.
Other studies have shown that mutations in WFDC1 were
associated with macular degeneration leading to blind-
ness,15e17 although mechanisms were not addressed.
In summary, previous studies suggest that WFDC1/ps20
may function as a regulator of diverse cell responses asso-
ciated with general homeostasis involving tissue repair and
immunity. To evaluate in vivo functions and address the
hypothesis directly, we generated a Wfdc1-null mouse to
assess the null phenotype and to pinpoint changes in host
response mechanisms during homeostasis challenges. We
report here that Wfdc1-null mice challenged with viral
infection or physical wounding exhibit clear biological al-
terations. Wfdc1-null mice exhibited marked resistance to
inﬂuenza virus infection and more robust wound repair re-
sponses with elevated and earlier recruitment of macro-
phages. These homeostasis responses were associated with
elevated Spp1/osteopontin and constitutively active matrix
metallopeptidase-9 (MMP-9) that mediated some ofWfdc1-
null associated biology. Together, these data suggest that
Wfdc1 represses emergency response mechanisms during
resting, normal adult tissue homeostasis and that release
from Wfdc1 regulation at sites of reactive and repair tissue
biology is a key permissive event in coordination of core
inﬂammatory and repair processes.
Materials and Methods
Wfdc1 Knockout/Knockin Mouse
A Wfdc1-null mouse was generated via knockout of exon 1
and insertion of lacZ inframe with the Wfdc1 ATG start
codon. The 50 homology arm using the Wfdc1 genomic
clone AF169632.1 was digested with SpeI, resulting in a
fragment containing nucleotides 2542 to þ418 (relative to
the ATG) (that includes exon 1) cloned into an SpeI site in
pSK- (Stratagene, Santa Clara, CA). An NcoI sense primer
50-GCCACCAGCCTCGCCATGGGTAACTGCG-30 (NcoI
site underlined) along with the anti-sense complement was
used in the Stratagene QuikChange Mutagenesis Kit to
mutate the Wfdc1 ATG to an NcoI site to generate the
construct pSpeINcoImutant. We then mutated the lacZ ATG2952to an NcoI site in the construct pPD46.21, obtained from
Dr. Franco DeMayo [Baylor College of Medicine (BCM)],
that contains a 3.3-kb lacZ fragment with an SV40 nuclear
localization site. A lacZ sense primer 50-CCGAGCTCA-
GAAACCATGGCTGCTCCAAAGAAGAAGCG-30 (NcoI
site underlined) along with the anti-sense complement was
used in the Stratagene QuikChange Mutagenesis Kit to
mutate the ATG from lacZ start to an NcoI site to generate
pPD46.21NcoImutant. The NcoI mutant constructs were
digested with NcoI and SalI, and the 3.3-kb lacZ NcoI
mutant fragment cloned into the pSpeINcoImutant
construct at the Wfdc1 ATG site to produce pSpeIßgal that
contains 2542 to þ1 ofWfdc1 and a 3.3-kb lacZ gene. To
generate a 30 homology arm using a XhoI to ApaI digest of
MGL5-II1S4, a Wfdc1 genomic clone containing exon 1
and part of intron 1, which generates a fragment fromþ549
to þ3883, was used. This 3334-bp 30 homology arm was
cloned in a 3-way ligation with the 50 homology arm from
the pSpeIßgal construct that was digested with ApaI and
XhoI to generate a fragment containing þ1170 toþ1 of the
Wfdc1 promoter with the 3.3-kb lacZ gene and a 1.7-kb
XhoI fragment from PGKNeo that contains the phospho-
glycerate kinase (PGK) promoter and neo gene cassette. All
three fragments were cloned into pSK- that was linearized
with ApaI to generate the Wfdc1KO/KI construct. The
orientation of the PGK-neo cassette was cloned in the anti-
sense direction relative to the lacZ gene. The Wfdc1KO/KI
construct was sequenced to verify position and orientation.
The Wfdc1KO/KI construct was then linearized with ApaI
and injected into AB2.2 p.13 embryonic stem cells by the
GEM core at BCM.
Chimeric mice were mated to C57Bl/6 mice for four to ﬁve
generations and given the name Wfdc1tm1LaczBCM. Use of
mice was carried out according to the Animal Welfare Act,
PHS Animal Welfare Policy, the principles of the NIH Guide
for the Care and Use of Laboratory Animals,18 and the pol-
icies of BCM.
Screening Wfdc1 Knockout Mice
The Wfdc1 knockout/knockin (KO/KI) mice were screened
by Southern blotting using a 1.3-kb probe spanning nucle-
otides þ2542 (SpeI) to þ1170 (ApaI). The introduction of
the lacZ gene produced an extra EcoRV site that on diges-
tion of the genomic DNA with EcoRV and hybridization
with the 1.3-kb SpeI-ApaI probe yielded a 6.5-kb knockout
allele and a 9.5-kb wild-type allele. Subsequently, mice
were screened by PCR using two reactions each containing
primers to mouse b-actin and either primers to Wfdc1exon1
sense (50-GGAGGTCACTCGTGCA-30) and Wfdc1 anti-
sense (50-CAGCATTGCCTCCCAA-30) or b-galactosidase
(b-gal) sense (50-TTCACTGGCCGTCGTTTTACAACG-
TCGTGA-30) and b-gal antisense (50-ATGTGAGCGAG-
TAACAACCCGTCGGATTCT-30). Screening with the
Wfdc1exon1 and b-gal primers yields 133-bp and 364-bp
bands, respectively.ajp.amjpathol.org - The American Journal of Pathology
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Tissues stained for b-gal enzyme were ﬁxed in 4% para-
formaldehyde for 1 to 2 hours, incubated in graduated 10%
to 20% sucrose (in Hanks’ balanced salt solution) over 3
days at 4C, and then frozen in optimal cutting temperature
compound. Frozen sections (10 mm) were postﬁxed in 0.2%
glutaraldehyde, washed seven times in PBS (pH 8.3), and
stained with X-Gal at 37C overnight (O/N). Following
staining for b-gal, some frozen tissues were also stained for
CD34, Mac-3, and pro-SP-C.
Immunostaining after b-Gal Enzyme Staining
For immunostaining after b-gal enzyme staining, the tissue
was evaluated for vessels using anti-mouse CD34
(#119301; BioLegend, San Diego, CA) at 1:100 dilution,
for macrophages using anti-mouse Mac-3 (BD Pharmingen
#553322; BD Biosciences, San Jose, CA) at 1:100 dilution,
or for type II pneumocytes using anti-mouse pro-SP-C
(WRAB-9337; Seven Hills Bioreagents, Cincinnati, OH) at
1:1600 dilution for 1 hour at room temperature.
Streptavidin-AP followed by Vector Red substrate (Vector
Laboratories, Burlingame, CA) was used to visualize the
immunostaining. Images were acquired using a CRi multi-
spectral deconvolution camera (N-MSI-420-FL) feeding a
Macintosh Mac Pro computer (Apple, Cupertino, CA)
running Nuance image analysis software version 3.0.0
(CRi, now PerkinElmer, Waltham, MA).
Immunostaining of Human Prostate
Human prostate sections were acquired from the Human
Tissue Acquisition and Pathology Core Laboratory (Dan L.
Duncan Cancer Center, BCM). An IgY antibody to a pep-
tide (CVKQRRQADGRILRHKLYKEY) at amino acids
180 to 200 of the human ps20 protein was made by Aves
Labs (Tigard, OR), tested for speciﬁcity, and used at 1:1200
dilution together with a rabbit anti-CD31 (#ab134168;
Abcam, Cambridge, MA) at 1:400 dilution O/N at 4C for
colocalization of ps20 and CD31. Secondary antibodies
[biotin-conjugated anti-chicken from Jackson Immuno-
Research Laboratories (West Grove, PA) #103-065-155 and
the horseradish peroxidase (HRP)-conjugated goat anti-
rabbit from Abcam #ab137913], were incubated for 45
minutes at 37C. To develop the chicken anti-ps20 anti-
body, Streptavidin-AP (Vector Laboratories) was incubated
(30 minutes at room temperature) followed by incubation
with the Vector Blue substrate (Vector Laboratories) (30
minutes at room temperature). To develop the rabbit anti-
CD31 antibody, the NovaRED substrate was incubated for
15 minutes at room temperature. Methyl Green (Vector
Laboratories) was used as a counterstain. Images were
converted to optical density (OD) and deconvoluted to
separate blue (anti-ps20) from the red (anti-CD31) and
green counterstain.The American Journal of Pathology - ajp.amjpathol.orgElectroretinogram
Four Wfdc1-heterozygous and four Wfdc1-null mice at 9
months of age for a total of eight eyes per group were tested
for a blindness phenotype using an electroretinogram pro-
tocol as described previously.19
Inﬂuenza Virus Infections
Wild-type, heterozygous, and null Wfdc1 KO/KI littermates
(12 to 16 weeks of age) were anesthetized (with isoﬂurane),
and 50 mL of approximately 10 median tissue culture infective
doses of inﬂuenza A/Texas (H1N1) virus was inoculated
intranasally. Mice were sacriﬁced at 4 days postinfection for
infectivity assays and at days 7 and 14 to assess histopathology
and immunohistochemistry (IHC). Lungs were harvested and
lobes were frozen in 1 mL of minimal essential medium in
tubes with glass beads, bead beaten, and then the supernatant
collected for virus titering or ﬁxed in 4% paraformaldehyde
and embedded in parafﬁn for IHC.
Inﬂuenza Virus Titering
Round-bottom plates (96 well) were prepared with MDCK
cells (CCL64; ATCC, Manassas, VA) 24 hours before
titering. The medium was changed to 100 mL of minimal
essential medium þ Worthington Trypsin (0.5%) to prepare
cells for viral infection. Frozen infected lungs were thawed
and bead beaten for 60 seconds. The homogenate was
centrifuged (5 minutes at 2000  g), and a 1:10 dilution in
minimal essential medium was made. Each mouse lung was
titered in duplicate with a control. Diluted lung homogenate
(50 mL) was added to 100 mL of medium, then serial dilutions
(1:3) were performed across the plate and the plate incubated
for 5 days at 37C in 5% CO2. Virus titer was determined by
adding 50 to 100 mL of red blood cells/well and incubating
for 30 minutes at room temperature. Statistical analysis of the
virus titer comparing infected heterozygous versus null lungs
was performed using an unpaired t-test with Welch’s
correction with the GraphPad Prism version 5 program
(GraphPad Software, La Jolla, CA).
IHC of Inﬂuenza-Infected Tissue
IHC analysis of both uninfected and inﬂuenza-infected mouse
tissues was performed as previously described20,21 with
modiﬁcations. Tissues were ﬁxed in Zinc ﬁxative (BD Phar-
mingen #550523; BD Biosciences) and processed for IHC
without antigen retrieval to assess macrophage, osteopontin,
and MMP-9 immunostaining. All secondary antibody in-
cubations were at 37C for 1 hour. To stain for macrophages,
IHC was performed on tissue from wild-type, Wfdc1-
heterozygous, and Wfdc1-null mice using rat monoclonal to
macrophage (Abcam #ab56297) 1:500 dilution at 4C O/N
and with biotin-conjugated goat anti-rat IgG, (Invitrogen
#D-20697; Life Technologies, Carlsbad, CA) 1:200 dilution.2953
Ressler et alTo stain for MMP-9, IHC was performed on infected lung
tissue from wild-type, Wfdc1-heterozygous, and null mice
using rabbit anti-mouse MMP-9 (Abcam #ab38898) at 1:200
dilution at 4C O/N and with biotin-conjugated goat
anti-rabbit IgG, (Invitrogen #B-2770) at 1:500 dilution. To
stain for osteopontin, IHC was performed on infected lung
tissue from wild-type, Wfdc1-heterozygous, and null mice
using goat anti-mouse osteopontin (#AF808; R&D Systems,
Minneapolis, MN) at 1:400 dilution at 4C O/N and with
biotin-conjugated donkey anti-goat IgG, (Invitrogen #D-
20698) at 1:500 dilution. Streptavidin-AP (Vector Labora-
tories #AK5000) and Vectastain Vector Red Substrate (Vector
Laboratories #SK5100) were used to visualize staining.
Wfdc1 KO/KI Cell Lines
Stromal cells were isolated as reported previously.1,22
Mouse lung, aorta, and prostate tissue were isolated from
Wfdc1-heterozygous and null KO/KI mice, minced, and
cultured in Bfs medium (DMEM; Gibco/Invitrogen) sup-
plemented with 5% fetal bovine serum, 5% Nu Serum (BD
Biosciences), 0.5 mg/mL testosterone, 5 mg/mL insulin, 100
U/mL penicillin, and 100 mg/mL streptomycin (Sigma-
Aldrich, St. Louis, MO) in 24-well plates. At conﬂuence,
cells were passed 1:2 dilution and maintained in T25 ﬂasks.
Spheroid Cultures and LPS or Poly I:C Treatment
For hanging-drop spheroid cultures, cells were trypsinized,
centrifuged at 400 g for 2 minutes, and resuspended in 8 mL
of Bfsmedium. Spots (25 to 30 20-mL spots) weremade on the
lid of a 100-mm2 dish and cultured for 4 to 5 days. The
spheroids were then collected and either plated onto a
100-mm2 plate for b-gal expression analysis using X-Gal as a
substrate or processed for RNA and subsequent gene expres-
sion analysis. For both lipopolysaccharide (LPS) and
polyinosinic-polycytidylic acid (poly I:C) treatment, the
Wfdc1 KO/KI stromal heterozygous and null cells were plated
onto 6-well plates and grown to 70% conﬂuence. The medium
was changed to serum-free medium Mo (MCDB 110 basal
medium supplemented with insulin, transferrin, and sodium
selenite; Sigma Diagnostics, Sigma-Aldrich)23 for 24 hours
and the cells treated with 2 mg/mL LPS (Sigma #L4391;
Sigma-Aldrich) or 50 mg/mL poly I:C (Sigma #P0913; Sigma-
Aldrich) in Momedium for either 6 hours for RNA analysis or
24 hours. For harvesting conditioned medium for protein and
zymography analysis, media from untreated and treated het-
erozygous and null cells were collected and either trichloro-
acetic acid precipitated for Western blot analysis or
concentrated in an Amicon Ultra-4 centrifugal ﬁlter (EMD
Millipore, Billerica, MA).
Superarray Analysis
RNA from either poly I:Ce or LPS-treated Wfdc1-hetero-
zygous and null mouse stromal cells was isolated (RNeasy2954Mini Kit; Qiagen, Valencia, CA). An oligo GEArray DNA
microarray to Mouse Autoimmune and Inﬂammatory
response (#OMM-803) and to the Toll-like receptor
pathway (#OMM-018.2) were used (SABiosciences, Fred-
erick, MD). Gene-speciﬁc primers for Spp1 were purchased
from Qiagen (#QT00157724). For superarray analysis of
Wfdc1 KO/KI stromal heterozygous and null stromal cell
spheroids, the Mouse Extracellular Matrix and Adhesion
Molecules (#OMM-013; SABiosciences) microarray was
used. Hybridization and digital analysis were performed
according to the manufacturer’s protocol.
RT-PCR and Quantitative PCR Analysis
For reverse transcription of mRNA, 500 ng of stromal cell
RNA was reverse-transcribed using the Superscript III kit
(Invitrogen) in 20 mL of reaction. For quantitative PCR
analysis, the RT reaction was diluted 1:5, and 5 mL was used
in a 96-well plate with the FastStart Universal SYBR
Green Master (Rox) kit (#04913914001; Roche, Basel,
Switzerland ) in 25 mL of ﬁnal volume. An ABI 7700 in-
strument (Life Technologies) was used with the following
program: 95C for 10 minutes and then 40 cycles of 95C
for 15 seconds and 60C for 30 seconds. mRNA expression
was quantitated relative to Gapdh mRNA levels, and anal-
ysis of the real-time PCR was performed using the DDCT
method.24
Zymography and Western Blotting
Three Wfdc1-heterozygous stromal cell lines (HetMP1,
HetMP3, and HetMP5) and two Wfdc1-null stromal cell
lines (312#1L1 and 312#2P1) were treated with LPS or poly
I:C as described above for 24 hours. Conditioned medium
was collected and concentrated in an Amicon Ultra-4 cen-
trifugal ﬁlter for zymography assays or concentrated by
10% trichloroacetic acid precipitation for Western blotting.
For zymography, one-third of the concentrated medium was
run on Bio-Rad ready-cast 10% gelatin gels (Bio Rad
Laboratories, Hercules, CA), and stained with Coomassie
Blue R-250 (Bio Rad Laboratories). For Western blotting,
one-third of the trichloroacetic acideprecipitated condi-
tioned medium was resuspended in 1 Nupage LDS sample
buffer (Invitrogen) and run on a 10% Nupage Bis-Tris
precast gel (Invitrogen) under reducing conditions.
Following transfer to a PVDF membrane using the iBlot
transfer apparatus (Invitrogen), the membrane was blocked
in Roche Western blocking reagent for 1 hour, incubated in
anti-mouse osteopontin (R&D Systems #AF808) at 0.2 mg/
mL at 4C O/N, followed by incubation in biotin-conjugated
donkey anti-goat antibody (Invitrogen #D20698) at 1:1000
dilution for 1 hour at room temperature, and then incubated
in Streptavidin-HRP (#RPN1239V; GE Healthcare, Chal-
font St Giles, UK) at 1:5000 dilution for 45 minutes at room
temperature. The blot was visualized using the Pierce ECL
substrate and scanned with a Kodak Image Station 4000Rajp.amjpathol.org - The American Journal of Pathology
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(Carestream Health, Rochester, NY).
In Vivo Wounding Assay and Immunostaining of Skin
Wounds
Two 3-mm-diameter punch biopsy lesions were made on the
ﬂanks ofWfdc1-heterozygous and null mice. A total of at least
ﬁve animals with two biopsies each were used to evaluate the
wound healing over 7 days in each group. From day 1 to 7, the
wounds were measured with calipers. The subsequent mea-
surements were analyzed using a two-way analysis of variance
analysis in GraphPad Prism version 5.0a. An additional ﬁve to
seven mice per genotype were wounded, and at day 7, wounds
were excised, ﬁxed in 4% paraformaldehyde O/N, and prepared
for parafﬁn sections as described above. Sections were stained
with Masson’s trichrome (Sigma #HT-15) and 4 images ac-
quired. Measurements of the wound border were made
using the Nuance software platform v.3.0.0 (PerkinElmer,
Hopkinton, MA). Wound gap measurements were analyzed
using a t-test analysis in GraphPad Prism. Sections of the 7-day
wounds were stained for anti-F4/80 (BioLegend #122601) at
1:50 dilution O/N at 4C with citrate retrieval, images decon-
voluted (Nuance system) to separate the red stain (F4/80) from
the blue hematoxylin stain, and the intensity overlap between
the red and blue calculated.
The calculated overlap intensity was then analyzed by a
U-test in GraphPad Prism. Additionally, 7-day wounds were
stained with antieKi-67 antibody (SP6 NeoMarkers RM-
9106-S0; NeoMarkers, Fremont, CA) at 1:200 dilution O/N at
4C with citrate retrieval. Images were deconvoluted to
separate the red stain (Ki-67) from the blue hematoxylin stain,
and the intensity overlap between the red and blue calculated.
The calculated overlap intensity was then analyzed by aU-test
in GraphPad Prism. Finally, the 7-day skin wounds were
stained with anti-osteopontin (Abcam #ab8448) at 1:200
dilution O/N at 4C and images acquired. All IHC staining of
the skin wounds used NovaRED (Vector Laboratories) as the
substrate for the peroxidase-conjugated enzyme, either HRP-
conjugated anti-rabbit (Epitomics #3051-1; Abcam) for rab-
bit antibodies or Streptavidin-HRP (Vector Laboratories), and
Mayer’s hematoxylin as the counterstain.
In Vitro Scratch and Adhesion Assay
Wfdc1-heterozygous and null stromal cell lines were grown
to conﬂuence in 6-well plates. Three pipette tips were
attached to a multichannel pipette, and three even scratches in
the monolayer were made per well. Images of the scratch
were taken at10 or20 at 0, 9, or 16 hours with a Spot RT
camera (SPOT Imaging Solutions, Sterling Heights, MI)
attached to a Nikon T300 inverted microscope (Nikon,
Tokyo, Japan). Using the Spot software version 5.0, the
scratch width was measured and analyzed using a t-test in
GraphPad Prism. The measurements were averaged from two
different Wfdc1-heterozygous and two different Wfdc1-nullThe American Journal of Pathology - ajp.amjpathol.orglines, and the assay was performed two independent times in
triplicate with three scratches per well.
For the anti-osteopontin migration inhibition assay, two
Wfdc1-null stromal cell lines 312#2P1 and 312#2L4 were
used in a scratch assay with the addition of either 10 mg of
IgG isotype control, or 10 or 20 mg of anti-osteopontin (R&D
Systems #AF808) added at time 0 hours following the
scratch. At 10 hours post scratch, images of the wound width
were photographed and analyzed as above. The anti-
osteopontin migration inhibition assay was performed in
triplicate with three scratches per well two independent
times. The scratch width in each image was measured in at
least three different places along the scratch. Individual t-tests
were performed comparing the control IgG with either 10 or
20 mg of anti-osteopontin IgG with both cell lines.
For the adhesion assay, two Wfdc1-heterozygous cell lines
(HetMA3 and Het MP1) and two Wfdc1-null cell lines
(312#2P1 and 312#2P4) were plated at 1000 cells/well on
96-well strips from a Millicoat ECM Screening Kit (Millipore
#ECM101-105) that contains individual 8-well strips coated
with either ﬁbronectin, laminin, vitronectin, collagen type I, or
collagen type IV. The assay was performed according to the
manufacturer’s directions and read at OD 540 nm with a Bio-
Rad iMark microplate reader. The adhesion assay was
performed in duplicate and repeated three independent times.
Two-way analysis of variance test with Bonferroni post-tests
was performed to compare the OD 540-nm measurements of
the extracellular matrix component for each Wfdc1-heterozy-
gous cell line versus each Wfdc1-null line.
Results
Phenotype of Wfdc1-Null Mice and Spatial Expression
of Wfdc1
To generate Wfdc1-null mice, exon 1 of the Wfdc1 gene was
deleted and the bacterial lacZ gene knocked in to the Wfdc1
locus to trace expression using homologous recombination as
described in Figure 1A. The resultingWfdc1-heterozygous and
homozygous null mice were evaluated for altered develop-
mental or adult tissue phenotypes. Wfdc1-heterozygous and
null mice exhibited no overt gross morphological or abnormal
tissue phenotypes during either embryonic development or
postnatal maturation. Reproductive rate, litter size, and sex
ratios of Wfdc1-null mice were each normal. This normal-
appearing phenotype is similar to null mice generated for
other WAP family members.25e27
Owing to reports of mutant WFDC1/ps20 being associated
with blindness, eye function was carefully evaluated. A
complete electroretinogram analysis showed no overt physi-
ological differences in retina function in Wfdc1-null and het-
erozygous mice (Supplemental Figure S1 and Supplemental
Table S1). The spatial and temporal patterns of Wfdc1
expression were evaluated by tracking the knockin nuclear
b-gal reporter, constructed with a SV40 nuclear localization
signal. Positive nuclear b-gal was observed in the adult mouse2955
Figure 1 Generation of Wfdc1 gene deletion and LacZ gene insertion at the ATG of the Wfdc1 gene. A: The insertion of the LacZ-PGKNeo cassette adds an
EcoRV site that is used to screen the mice by Southern analysis. Using a 1.3-kb probe, after digesting the genomic DNA with EcoRV, the knockout and wild-type
alleles are 6.5 and 9.5 kb, respectively. Wild-type, heterozygous (Het), and Null lanes show 9.5-kb, 6.5- and 9.5-kb, and 6.5-kb bands, respectively. For sub-
sequent PCR screening, Actb, lacZ, andWfdc1 primers produced a 500-bp, 364-bp, and 133-bp band, respectively. Lane 1 (wild-type) contains the Wfdc1 band, but
no lacZ band. Lane 2 (Wfdc1-null mouse) shows lacZ band, but no Wfdc1 band. Wfdc1-heterozygous mouse exhibits both a Wfdc1 and lacZ band. BeI: Staining for
Wfdc1 expression in mice and human prostate. Positive staining (blue precipitate) for reporter b-gal expression in frozen sections are observed in the inner
nuclear layer and ganglion cell layers in the retina (B), the epithelial cells of the ventral prostate (C), sporadic cells in the epidermal layer of the skin (D), sporadic
smooth muscle cells of the bladder (E), the endothelial cells of the testes (inset image is colocalization of b-gal staining in blue with CD34 in red) (F), endothelial
cells of the lung alveoli (inset image is colocalization of b-gal staining in blue with anti-CD34 in red) (G), endothelial cells of the capillaries of the brain (inset
image is colocalization of b-gal staining with anti-CD34 in red) (H), the epithelial cells in prostate acini and endothelial cells of vessels in the human prostate
(colocalization of anti-ps20 in blue and anti-CD31 in red) (I). Scale bars: 50 mm (main images, BeI); 25 mm (insets, FeH).
Ressler et alretina (Figure 1B), prostate (Figure 1C), skin (Figure 1D),
bladder (Figure 1E), testis (Figure 1F), lung (Figure 1G), and
brain (Figure 1H), and in the human prostate gland (Figure 1I).
Other mouse tissues such as the liver, spleen, thymus, kidney,
and bone did not exhibit obvious nuclear b-gal staining. Of
interest, b-gal staining was observed in cells within the walls
of the microvasculature in many tissues.
Colocalization of b-gal expression with anti-CD34
demonstrated that Wfdc1 expression was spatially associated
with endothelial cells in small vessels in the brain, lung, and
testes (Figure 1, FeH). Wfdc1 expression was not spatially
associated with either macrophages or type II pneumocytes in
the lung (Supplemental Figure S2). In the retina, most cells in
the inner nuclear layer and a few cells in the outer nuclear layer
exhibited intense nuclear b-gal (Figure 1B). Epidermal cells of
the skin and smooth muscle cells of the bladder exhibited
sporadic expression of nuclear b-gal (Figure 1, D and E).
Prostate gland exhibited a more general nuclear localization of
b-gal in the acinar epithelial cells (Figure 1C). This spatial
pattern of b-gal activity is consistent with immunolocalization
of actual WFDC1/ps20 in the human prostate gland, where2956ps20 is spatially localized in prostate acinar epithelial cells and
vascular, CD31-positive endothelial cells (Figure 1I).
Together, these data are consistent with the notion that
WFDC1/ps20 is localized to cells with a relatively high ad-
hesive and barrier function. This includes endothelial cells
where there is a bloodetissue barrier (brain and testis); lung,
where the endothelial barrier is critically important; retina
layers that exhibit high adhesion; and epithelial cells associ-
ated with barrier function in the prostate gland.
WFDC1 Affects Inﬂuenza Virus Infection
Owing to our previous studies that showed WFDC1/ps20
exhibits an immunomodulatory role that promotes HIV
infection in vitro,13 we investigated whether WFDC1/ps20
status affects inﬂuenza A infection in lung tissue. Wild-type,
Wfdc1-heterozygous, and Wfdc1-homozygous null mice
were subjected to lung infection with inﬂuenza A/TX.
Remarkably, viral titers in lung tissue at 4 days postinfection
showed a 2.75elog-fold lower titer in Wfdc1-null mice
as compared to Wfdc1-heterozygous mice (Figure 2A)ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Wfdc1-null mice exhibit resistance to inﬂuenza virus infection
concordant with an increase in macrophage recruitment. A: The Wfdc1-null
mice exhibit a signiﬁcant resistance to lung inﬂuenza A viral infection by
2.75-logs lower viral titer in lung tissue at day 4 postinfection. BeD:
Immunohistochemistry for macrophage recruitment (anti-mø) shows
elevated accumulation in day 7 Wfdc1-null mice infected lungs relative to
day 7 control wild-type or Wfdc1-heterozygous (Het) mice infected lungs.
Error bars show the standard error of the mean. ***P < 0.005. Original
magniﬁcation: 200 (BeD). Ab, antibody.
Wfdc1 Regulates Homeostasis(P < 0.005). Viral titers in the wild-type mice were similar
to Wfdc1-heterozygous mice. To assess whether levels of
viral infectivity were associated with differences in immune
cell inﬁltration, the 7-day postinfection lungs were evalu-
ated for macrophage and neutrophil recruitment. A consid-
erable elevation in macrophage recruitment was observed in
the infected lung tissue in Wfdc1-null mice as compared to
the infected wild-type and heterozygous lung tissue
(Figure 2, BeD). No differences were observed in neutro-
phil immunoreactivity.
WFDC1 Affects Rate of Wound Closure
In addition to reports implicating the WAP-family members,
Slpi28 and elaﬁn29 in wound repair, we8 have published that
WFDC1/ps20 is down-regulated during reactive stroma for-
mation in the progression of prostate cancer, where reactive
stroma exhibits hallmarks of a wound repair response.30e32
Accordingly, the Wfdc1-null and heterozygous mice were
evaluated for alteration in wound repair subsequent to
3-mmediameter full-thickness skin wounds. Evaluating
wound gaps over a 7-day skin wound healing assay,
Wfdc1-null mice exhibited a signiﬁcant increase in rate of
wound closure from days 5 to 7. By day 6, the wound gap in
Wfdc1-null mice had signiﬁcantly decreased to 46% of the
starting wound gap as compared with a decrease to 62% of the
starting gap in Wfdc1-heterozygous mice (P < 0.05)
(Figure 3A). By day 7,Wfdc1-null mice exhibited 28%wound
gap as compared with 46% in Wfdc1-heterozygous mice
(P < 0.05). All tissues were harvested at day 7 and processed
for IHC. Evaluation of wound repair tissues stained with
Masson’s trichrome, to assess reactive stroma, exhibited
signiﬁcant differences (Figure 3B). Measurements from
microscopic evaluation of transverse sections showed that
Wfdc1-null mice averaged a 1086-mmwound gap as compared
with a 1400-mm wound gap for Wfdc1-heterogeneous mice
(P < 0.05) (Figure 3B). IHC followed by deconvolution mi-
croscopy and quantitative image analysis showed a signiﬁcant
elevation and considerably more heterogeneity in macrophage
recruitment in theWfdc1-null mice (587 median OD value) as
comparedwith theWfdc1-heterozygousmice (200medianOD
value) (P < 0.05) (Figure 3C). Similar to the lung infection
experiments, no signiﬁcant differences were observed in
neutrophil inﬁltration. To determine the stage of wound repair,
day 7 wounds were evaluated for Ki-67 staining by decon-
volution microscopy and quantitative image analysis. During
classical wound healing, cellular proliferation occurs during
the second, or tissue formation, stage, whereas a decrease in
proliferative cells occurs during the third, or tissue regenera-
tion, stage.33 A signiﬁcant decrease in Ki-67 staining intensity
was observed with the Wfdc1-null mice (13,772 median OD
value) as compared with Wfdc1-heterozygous mice (24,537
median OD value) (Figure 3D). The lower Ki-67 staining in-
tensity in both the epithelium and transitional stroma at day 7
in the Wfdc1-null mouse is consistent with a more advanced
wound closure as compared with heterozygous mice.The American Journal of Pathology - ajp.amjpathol.orgElevated Spp1 Osteopontin Expression in Wfdc1-Null
Cells
To assess mechanisms of WFDC1/ps20 action in mediating
inﬂammatory responses, ﬁbroblast cell lines were derived
from Wfdc1-null and heterozygous mice. To evaluate differ-
ential inﬂammatory responses, the cell lines were treated with
either LPS or poly I:C to simulate bacterial and viral infections,
respectively. Gene expression proﬁling revealed an enhanced
inﬂammatory gene expression signature (Supplemental
Figure S3). Genes differentially up-regulated in Wfdc1-null
cells included tumor necrosis factor-a (TNF-a), IL-1b,
IL-12b, granulocytic macrophage colony stimulating factor 3
(GM/CSF3), and Cox 2 (prostaglandin E synthase, Ptges). Of
interest, expression of keratinocyte chemokine (KC) (murine
homolog of IL-8) in response to both poly I:C and LPSwas not
induced nearly as high inWfdc1-null cell lines (approximately
40-fold less) as compared to Wfdc1-heterozygous cell lines
(Supplemental Figure S4). The FGFR1 gene did not show an
increased expression in response to the inﬂammatory agents
LPS and poly I:C.
We have reported previously that WFDC1/ps20 regulates
differential cell piling and cell shape in prostate smooth
muscle cell lines.5 In addition, elevated WFDC1/ps20
expression was associated with cell adhesion in spheroid
formation in cultures of prostate stromal cells.3 Accordingly,
we evaluated expression proﬁles of genes encoding cell
adhesion proteins, both in the context of a proinﬂammatory
stimulus and in the context of spheroid formation, to assess
alterations associated with Wfdc1-null conditions. This2957
Figure 3 Wfdc1-null mice exhibit an elevated wound repair response concordant with an increase in macrophage recruitment. A: A signiﬁcant difference in
wound closure is observed in Wfdc1-null mice at days 6 and 7 relative to Wfdc1-heterozygous (Het) mice. B: Representative 4 trichrome images of the 7-day
wounds of heterozygous and null mice were used to measure the wound gap (measurement lines are shown in the images). Quantitative analysis of the wound
gap shows that wounds of Wfdc1-null mice exhibit a signiﬁcantly elevated rate of closure as compared with heterozygous mice. C: Using the Nuance mul-
tispectral camera, micrographs (representative images) were analyzed using the Nuance software to calculate the percent F4/80-positive staining (red) that
colocalized with nuclei (blue, hematoxylin; colocalization, yellow). Quantitative analysis of the overlap staining intensity (colocalization) shows that the
7-day skin wound of Wfdc1-null mice contains signiﬁcantly more macrophage as compared with heterozygous mice. D: Micrographs (representative images)
were analyzed quantitatively to calculate the percentage of Ki-67 (red) immunostaining that colocalized with nuclei (blue, hematoxylin; overlap, yellow).
Wfdc1-null mice 7-day skin wounds contain signiﬁcantly fewer Ki-67 staining cells as compared with heterozygous mouse 7-day skin wounds, reﬂecting a more
completed repair process. Error bars show the standard error of the mean. *P < 0.05 (AeD). Scale bars: 500 mm (B and C).
Ressler et alrevealed that in Wfdc1-null conditions, Opn (Spp1) was the
only adhesion-related gene that was up-regulated in both
inﬂammatory conditions (poly I:C treatment) and during
spheroid formation (hanging-drop cultures) (Figure 4, A
and B). Opn expression was up-regulated 62-fold higher in
Wfdc1-null cells relative to Wfdc1-heterozygous cells after
exposure to poly I:C (Figure 4A). Western blot analysis
showed that Wfdc1-heterozygous cells secreted very little
osteopontin, whereas Wfdc1-null ﬁbroblasts secreted both
more full-length and cleaved osteopontin protein, known to
be the activated forms (Figure 4B). Osteopontin levels also
correlated with the ability to form spheroids in hanging-drop
cultures. Wfdc1-heterozygous cells formed typical spheroids
in hanging-drop cultures (Figure 4C). However, Wfdc1-null
cells were completely restricted from spheroid formation in
hanging-drop cultures, were negative for nuclear reporter
b-gal during spheroid culture conditions, and exhibited a
2.3-fold elevation in Opn message relative to Wfdc1-
heterozygous cell spheroids (Figure 4C).
Owing to the elevated expression in Wfdc1-null cells, IHC
for osteopontin was evaluated in the inﬂuenza Aeinfected
lungs and in day 7 wound repair tissues to determine whether
elevated osteopontin protein associated with the null pheno-
type. Consistent with the in vitro ﬁndings, considerably more2958intense osteopontin immunoreactivity was observed in both
the inﬂuenza-infected lung tissue and the 7-day skin wound
tissue in the Wfdc1-null mice relative to Wfdc1-heterozygous
mice (Figure 4D).
Wfdc1-Null Cell Lines Exhibit Rapid Migration/Closure
and Altered Adhesion Properties in Vitro
Consistent with the in vivo data, Wfdc1-null cells in vitro
exhibited signiﬁcantly elevated migration in wounding
scratch assays in culture, as compared with Wfdc1-hetero-
zygous cells (Figure 5A). At 9 hours, Wfdc1-null cells
exhibited a signiﬁcant increase in closure and had migrated
an average of 506 mm as compared with an average of 244
mm with the heterozygous cell lines (P < 0.005).Wfdc1-null
cells achieved near full closure by 16 hours (655-mm
migration), whereas the Wfdc1-heterozygous lines displayed
signiﬁcantly less closure (516 mm) (P < 0.005) (Figure 5A).
To assess whether the increased migration ofWfdc1-null cells
was attributable to elevated osteopontin activity, neutralizing
antibody was added to two different null cell lines (P1 and
L4) subsequent to scratch wounding. Osteopontin neutral-
izing antibody inhibited wound closure in the P1Wfdc1-null
line relative to control at both 10 mg (358-mm migration)ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Elevated message and protein expression of osteopontin in Wfdc1-null stromal cell lines, inﬂuenza-infected Wfdc1-null lungs, and Wfdc1-null
7-day skin wounds. A: Expression of osteopontin mRNA is elevated 3.26-fold in poly I:Cetreated Wfdc1-null cells as compared with poly I:Cetreated Wfdc1-
heterozygous (Het) cells as assessed by hybridization arrays. Quantitative PCR (qRT-PCR) analysis of poly I:Cetreated Wfdc1-null stromal cells veriﬁes that
osteopontin mRNA is increased 62.2-fold relative to poly I:Cetreated Wfdc1-heterozygous stromal cells. B: Three Wfdc1-heterozygous stromal cell lines
(HetMP1, -3, and -5) show relatively low levels of osteopontin protein (OPN) secreted into conditioned media. Comparatively, the Wfdc1-null stromal cell lines
(312#1L1 and 312#1P1) show an increase in full-length osteopontin (arrow) and cleavage products. C: Spheroids were formed in hanging-drop cultures for 4
to 5 days, plated, and then stained for b-gal expression (blue). Wfdc1-null cells were restricted from spheroid formation and did not stain for reporter b-gal
expression as compared with tight spheroidal organization and positive b-gal staining in hanging-drop cultures generated with Wfdc1-heterozygous stromal
cells. Screening an extracellular matrix and adhesion molecule expression array from SABiosciences shows a 2.3-fold increase in osteopontin expression in the
null spheroids. D: IHC reveals an elevated staining intensity for osteopontin (red) in Wfdc1-null infected lungs and 7-day skin wounds as compared with Wfdc1-
heterozygous tissue controls. Original magniﬁcation, 200 (C and D).
Wfdc1 Regulates Homeostasisand 20 mg (303-mm migration) concentrations relative to
control conditions (458-mm migration) (Figure 5B)
(P < 0.01). In the L4 cell line, osteopontin neutralizing
antibody again signiﬁcantly inhibited at 10 mg (257-mm
migration) and 20 mg (179-mm migration) relative to con-
trol conditions (395-mm migration) (Figure 5B). No sig-
niﬁcant differences were found in cell proliferation of the
Wfdc1-null cells as compared with theWfdc1-heterozygous
cells in vitro. Together, these results suggest that Wfdc1-
null cells exhibit elevated cell migration and that this was
mediated by elevated osteopontin secreted by the Wfdc1-
null cells.
Because wound repair migration is affected by differential
cell adhesion and contraction, adhesion to several matrix
proteins that are expressed at sites of wound repair was
evaluated. Of these, the Wfdc1-null cell lines exhibited
signiﬁcantly increased adhesion to both ﬁbronectin and
laminin relative to Wfdc1-heterozygous cells (Figure 5C).The American Journal of Pathology - ajp.amjpathol.orgHowever, no changes were observed in cell adhesion to
vitronectin, collagen I, or collagen IV.
Wfdc1-Null Cells Express Elevated MMP-9 Activity
Several studies have implicated MMP activity in
osteopontin-mediated adhesion and migration.34e36 More-
over, MMP-9 has been shown to cleave osteopontin into
fragments that promote cell migration and the metastatic
potential of cancer cells.37,38 Hence, we evaluated whether
MMP activity was altered in Wfdc1-null cells. Elevated
levels of biologically active forms of MMP-9 were found in
Wfdc1-null cell lines (312#1L1 and 312#1P1) as compared
with Wfdc1-heterozygous cell lines (HetMP1, -3, and -5) as
shown by gelatin zymography (Figure 6A). By contrast, the
levels of MMP-2 were similar in all cell lines, irrespective of
Wfdc1 status. Interestingly, the levels of active MMP-9 in
Wfdc1-null cells in steady-state conditions were similar to2959
Figure 5 Elevated cell migration and adhesion properties in Wfdc1-null
stromal cells. A:Wfdc1-null stromal cells exhibit signiﬁcant increase in closure
rates of in vitro scratch assays at both 9 and 16 hours relative to Wfdc1-het-
erozygous cells (P < 0.005). B: Incubation with osteopontin (OPN) neutral-
izing antibody (at both 10 and 20 mg) signiﬁcantly decreases in vitro wound
closure in two independent null cell lines (312#P1 and 312#2L4) relative to an
IgG control antibody (P< 0.01). C:Wfdc1-null stromal cell lines (312#2P1 and
312#2P4) display signiﬁcantly more adhesion to both ﬁbronectin and laminin
compared to Wfdc1-heterozygous stromal cell lines (HetMA3 and HetMP1).
Error bars show the standard error of themean. Black bars, laminin; white bars,
ﬁbronectin. **P < 0.01, ***P < 0.005.
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2960levels in LPS-treated conditions, showing that Wfdc1-null
cells not only exhibit a higher level of osteopontin, but also
express constitutively active MMP-9 as compared with
Wfdc1-heterozygous cell lines. Although activation levels
were different, there appeared to be similar levels of total
protein irrespective ofWfdc1 status. IHC analysis of MMP-9
in infected lung tissue showed that immunoreactivity was
approximately the same in the wild-type, Wfdc1-heterozy-
gous, and Wfdc1-null inﬂuenza-infected lung tissue
(Figure 6B), suggesting the level of total protein expression
does not differ in the infected lung tissue. These data suggest
that MMP-9 protein is constitutively active in Wfdc1-null
conditions even though total protein is similar to
Wfdc1-heterozygous conditions. These data may explain the
elevated levels of cleaved (activated) osteopontin observed in
Wfdc1-null conditions, because MMP-9 is known to cleave
and produce osteopontin fragments that promote cell
migration/invasion.38Discussion
Interestingly, knockout of Wfdc1 resulted in no overt
developmental or adult tissue phenotype, similar to what has
been reported for other WAP family members. However,
differential biological responses were evident during chal-
lenges to homeostasis in adult tissues. Importantly, Wfdc1-
null mice exhibited a signiﬁcant elevation in resistance to
inﬂuenza A virus infection and a more rapid cutaneous
wound repair response. Both these responses were associ-
ated with elevated recruitment of macrophages and elevated
expression of osteopontin. Moreover, Wfdc1-null cells
exhibited elevated secretion of constitutively active
MMP-9, an enzyme that is important in osteopontin pro-
cessing to active fragments among other biological activ-
ities.37 Consistent with this notion, elevated expression of
both full-length and cleaved osteopontin was observed in the
Wfdc1-null condition. The cleaved osteopontin fragments
have been associated with elevated migration and metastasis
in cancer. Wfdc1-null cells in vitro also exhibited altered
adhesion and rapid closure in scratch assays, consistent with
in vivo results. Together, these results suggest thatWfdc1 is
not likely involved in embryological development or adult
normal steady-state biology; however, it is a key repressor
and modulator of critical aspects of response mechanisms
that operate during disrupted tissue homeostasis. As such,
Wfdc1 may be one of the genes best described as being
associated with modulating emergency biology. Consistent
with this suggestion, osteopontin has also been shown to be
associated with a wide variety of emergency biology
responses.
Osteopontin is a matricellular protein expressed by a num-
ber of cell types, including macrophages, smooth muscle,
endothelial cells, and retinal Müller cells.39,40 In addition,
osteopontin is important in wound repair, ﬁbrosis resolution,
and host responses to microbial infection.41e43 Osteopontin isajp.amjpathol.org - The American Journal of Pathology
Figure 6 Increased gelatinase activity in un-
treated Wfdc1-null cells. A: Three Wfdc1-heterozy-
gous (Het) stromal cells lines express MMP-2 at
nearly similar levels when untreated or treated
with lipopolysaccharide (LPS), whereas Wfdc1-null
stromal cell lines also express increased MMP-9
activity in both untreated and LPS-treated condi-
tions. B: IHC for MMP-9 (red) in Wfdc1 wild-type,
heterozygous, and null inﬂuenzaeinfected lungs
shows similar staining intensity and localization of
staining in vessels (asterisks), bronchioles (dou-
ble daggers), and macrophages (arrows). Original
magniﬁcation, 200 (B).
Wfdc1 Regulates Homeostasisa potent chemokine in the recruitment of macrophages during
inﬂammatory reactions41,44 and in modulating cell migration/
invasion.37,38 The biological responses noted in Wfdc1-
homozygous null conditions are fully consistent with elevated
osteopontin activity, including altered cell migration, adhe-
sion, spheroid formation in vitro, and recruitment of macro-
phages. This was particularly evident in the day 6 and day 7
wound repair study, where the timeline of more rapid closure
was congruent with elevated osteopontin and macrophage
recruitment. Osteopontin has not been previously associated
with WAP family members. Considerable heterogeneity was
observed in the elevated macrophage recruitment in the
Wfdc1-homozygous null conditions, and this may relate to
elevated osteopontin expression. How osteopontin and mac-
rophages may affect wound contraction by myoﬁbroblasts is
not yet understood. However, osteopontin has been shown to
be required for TGF-b1einduced myoﬁbroblast differentia-
tion.45 Hence, the more rapid wound repair inWfdc1-null mice
could result, in part, from the actions of elevated osteopontin
onmyoﬁbroblast differentiation or function. It follows that low
expression of WFDC1/ps20 observed at sites of reactive
stroma8 may be associated with myoﬁbroblast biology, known
to be important in reactive stroma.
The observation that basal MMP-9 activity was increased
in Wfdc1-null cells is consistent with the biology observed
in the Wfdc1-null mice. Osteopontin has been shown to
up-regulate MMP-9 expression,35 and macrophage- and
epithelial cell-derived MMP-9 cleaves osteopontin.46 Other
WAP family members, SLPI and WFDC2, can also
modulate the activity of MMP-9.47e49 Moreover, inﬂam-
matory macrophage migration is dependent on
plasminogen-cleaved MMP-9.50 Observing both up-
regulated MMP-9 activity and osteopontin overexpression
and cleavage in the LPS-treated Wfdc1-null cells establishes
Wfdc1 as a modulator of this osteopontineMMP-9 axis.The American Journal of Pathology - ajp.amjpathol.orgFurthermore, we have shown that WFDC1/ps20 expression
in the stromal compartment in human prostate cancer is
decreased, whereas cancer/epithelial expression is
increased; however, cancer cells were shown to express a
novel splice variant of WFDC1.8,51 Hence, it is possible that
altered WFDC1/ps20 expression modulates cancer cell
migration/invasion, which could affect metastasis.
As determined by the knockin reporter, expression of
Wfdc1 was observed in cells that exhibit a high adhesive,
barrier function, among other features: notably, endothelial
cells at the bloodebrain barrier, endothelial cells at the
bloodetestis barrier, skin epidermal cells, prostate epithe-
lium, retina layers, and smooth muscle in the bladder.
Corroborating the brain endothelialespeciﬁc expression,
another study identiﬁed Wfdc1 as both a bloodebrain bar-
rier and endothelial-enriched transcript relative to periph-
eral endothelial cells and pericytes.52 The expression in the
retinal inner nuclear layer is consistent with an additional
study that showed thatWfdc1 is in the top 11% of genes that
are expressed in the inner nuclear layerespeciﬁc Müller
cells.53 In addition, localization of WFDC1/ps20 changed
during retinal development in Chx10-null mice, where
Chx10 has been shown to be a retinal progenitor cell and
Müller cellespeciﬁc gene.53,54 Together, these data suggest
that WFDC1/ps20 is likely an important regulator of retina
biology, although we did not observe vision-related phe-
notypes associated with Wfdc1-null conditions.
WFDC1 is unique among the human WAP family
members. WFDC1 is not located in chromosome 20q13,
which contains 19 genes with either a WAP or Kunitz-type
domain in a region shown to undergo strong genetic se-
lective pressure.55e57 Most of the 20q13 WAP genes, such
as SLPI and PI3 (SKALP, elaﬁn), exhibit antimicrobial
activity and antiprotease activity.6,7 Most of the 20q13
WAP genes are up-regulated following changes in tissue2961
Ressler et alhomeostasis and appear to attenuate the innate host
response.58e60 By contrast, WFDC1/ps20 is down-
regulated in cancer, speciﬁcally in the stroma,8,51,61e64
and stimulates response mechanisms. WFDC1/ps20 was
down-regulated in two models of in vivo activation of he-
patic stellate cells, which are cells most responsible for
liver ﬁbrosis.65 We have now shown that Wfdc1-null mice
exhibited augmented tissue repair/inﬂammatory responses
during both inﬂuenza infection and skin wound repair. It
could be surmised that down-regulated expression or
activity of WFDC1/ps20 is required in barrier cells to
signal-activated tissue responses leading to recruitment of
inﬁltrating cells. In addition to expressing more proin-
ﬂammatory chemokines, like osteopontin, these cells also
express other WAP family members such as SLPI and PI3.
Wfdc1-null cells also expressed an increased inﬂammatory
gene proﬁle, however with a conspicuous lack of KC
overexpression. The other WAP family members that have
been studied seem to regulate IkB degradation and subse-
quent NF-kB signaling.66 The lack of a full proin-
ﬂammatory gene proﬁle argues against WFDC1/ps20
regulating the NF-kB signaling pathway in the same way as
the other WAP family members, although this requires
further study.
The present report suggests that WFDC1/ps20 is a
fundamental regulator of diverse inﬂammatory and wound
repair responses. Elevated or basal levels of WFDC1/ps20
would be expected to sustain adult differentiated biology,
whereas down-regulated WFDC1/ps20 expression or
activity would induce a permissive switch to a repair/in-
ﬂammatory biology that is required to clear microorgan-
isms, and to affect a repair response typiﬁed by elevated
stromal cell migration and matrix remodeling. Homeo-
stasis after the repair might then be associated with a
resumed expression or activity of WFDC1/ps20 and a
return to an inﬂammatory-quiescent, adult differentiated
biology state. Hence, determining the mechanisms that
regulate Wfdc1 expression and functions will help further
elucidate how this protein and the downstream biology
affects core responses and modulation of tissue homeo-
stasis. These mechanisms will be important to the design
of novel therapeutic approaches to treating microbial
disorders, inﬂammatory responses, and altered wound
repair responses.Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2014.07.013.References
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